摘要
目的:探讨腹水超滤浓缩回输腹腔技术治疗肝炎肝硬化顽固性腹水的临床疗效。方法:选取肝炎肝硬化顽固性腹水患者60例,随机分为治疗组和对照组,治疗组在保肝、利尿、对症、支持等常规治疗基础上,采用腹水超滤浓缩回输腹腔治疗;对照组在常规治疗基础上,采用多次治疗性腹穿放液治疗。疗程均为4周。结果:治疗组临床疗效明显好于对照组(P<0.05);治疗组腹水蛋白及补体C3水平明显高于对照组(P<0.05);血清白蛋白水平明显高于对照组(P<0.05)。结论:腹水超滤浓缩回输技术治疗肝炎肝硬化顽固性腹水能取得很好疗效,值得临床应用。
Objective：To evaluate the clinical efficacy of ascites tdtrafiltration concentration back -transfusion treatment for posthepatitic cirrhosis complicating refractory aseites. Methods：60 patients with posthepatitie cirrhosis complicating refractory ascites were randomly divided into treatment group and control group. Patients in both groups received conventional therapy for 4 weeks. Patients in treatment group received the ascites uhrafihration concentration back- transfusion concomitantly, while patients in control group received abdominal paracentesis apocenosis. Results ： The clinical efficacy of study group was better than that of control group （ P 〈 0.05 ）, protein and complement C3 levels in ascites in study group were better than that in control group （ P 〈 0.05 ）, serum albumin level in study group was better than that in control group （ P 〈 0.05 ）. Conclusions： It is efficacy and safety of the ascites ultrafiltration concentration back -transfusion treatment for posthepatitic cirrhosis complicating refractory aseites.
出处
《中国民康医学》
2010年第9期1082-1083,共2页
Medical Journal of Chinese People’s Health
关键词
肝炎肝硬化
顽固性腹水
腹水超滤浓缩
Posthepatitic cirrhosis
Refractory aseites
Ascites uhrafihration concentration
